These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 30704681)

  • 1. The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.
    Atri A
    Med Clin North Am; 2019 Mar; 103(2):263-293. PubMed ID: 30704681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and Future Treatments in Alzheimer's Disease.
    Atri A
    Semin Neurol; 2019 Apr; 39(2):227-240. PubMed ID: 30925615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Management of Dementia: Review.
    Arvanitakis Z; Shah RC; Bennett DA
    JAMA; 2019 Oct; 322(16):1589-1599. PubMed ID: 31638686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
    Hane FT; Robinson M; Lee BY; Bai O; Leonenko Z; Albert MS
    J Alzheimers Dis; 2017; 57(3):645-665. PubMed ID: 28269772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.
    Forlenza OV; Diniz BS; Teixeira AL; Stella F; Gattaz W
    Braz J Psychiatry; 2013; 35(3):284-94. PubMed ID: 24142092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of Alzheimer's disease.
    Desai AK; Grossberg GT
    Neurology; 2005 Jun; 64(12 Suppl 3):S34-9. PubMed ID: 15994222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of Alzheimer's disease--an update.
    Srinivas P
    Med J Malaysia; 1999 Dec; 54(4):541-9; quiz 550. PubMed ID: 11072482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFNS guidelines for the diagnosis and management of Alzheimer's disease.
    Hort J; O'Brien JT; Gainotti G; Pirttila T; Popescu BO; Rektorova I; Sorbi S; Scheltens P;
    Eur J Neurol; 2010 Oct; 17(10):1236-48. PubMed ID: 20831773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.
    van Reekum R; Simard M; Farcnik K
    Can Fam Physician; 1999 Apr; 45():945-52. PubMed ID: 10216793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial.
    Forstmeier S; Maercker A; Savaskan E; Roth T
    Trials; 2015 Nov; 16():526. PubMed ID: 26576633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
    de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
    J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.